[LXRX] YoY Quarter Result on 30-Jun-2023 [#Q2]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
04-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -45.30%
YoY- -78.42%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 1,647 317 35 234 9,163 9,682 13,753 -29.76%
PBT -53,429 -44,904 -24,587 -18,067 -69,071 -23,018 -34,706 7.44%
Tax 0 1,152 580 19 5,125 -219 6,097 -
NP -53,429 -44,904 -25,167 -18,067 -69,071 -23,018 -34,706 7.44%
Tax Rate - - - - - - - -
Total Cost 55,076 45,221 25,202 18,301 78,234 32,700 48,459 2.15%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -3,244.02 -14,165.30 -71,905.71 -7,720.94 -753.80 -237.74 -252.35 52.99%
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -0.17 -0.22 -0.17 -0.13 -0.65 -0.22 -0.33 -10.45%
EPS Diluted -0.17 -0.22 -0.17 -0.13 -0.65 -0.22 -0.33 -10.45%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.